Drugs (Pharmaceuticals) – Page 46

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

By Rebecca Robbins

Brain Drugs (Pharmaceuticals) Eli Lilly and Company Research

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

By Gina Kolata

Drugs (Pharmaceuticals) Elderly Food and Drug Administration Guillain-Barre Syndrome Respiratory Diseases Sanofi SA Vaccination and Immunization

RSV Vaccine Approved for Older Adults

The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.

By Christina Jewett

Drugs (Pharmaceuticals) National Academies of Sciences, Engineering and Medicine Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Philanthropy Purdue Pharma Sackler Family Science and Technology United States United States Politics and Government

National Academies Members Demand Answers About Sacklers’ Donations

The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.

By Christina Jewett